| Title | Available Formats |
What Are These Drugs?
Updated March 2009
|
|
Screening and Ongoing Assessment for Substance Use
Updated November 2007
|
|
Working With the Active User
Updated October 2006
|
|
Substance Use Treatment Modalities for HIV-Infected Substance Users
Posted January 2008
|
|
Clinical Management of Alcohol Use and Abuse in HIV-Infected Patients
Posted April 2008
|
|
Smoking Cessation in HIV-Infected Patients
Updated February 2008
|
|
Aspects of Primary Care for the HIV-Infected Substance User
Updated February 2009
|
|
Adherence to Antiretroviral Therapy Among Substance Users
Updated June 2005
|
|
Drug-Drug Interactions Between ARV Agents, Medications Used in Substance Use Treatment, and Recreational Drugs
Updated March 2008
|
|
Pain in the HIV-Infected Substance User
Updated August 2005
|
|
Mental Health Disorders Among Substance-Using HIV-Infected Patients
Posted March 2008
|
|
Medical Care of HIV-Infected Substance-Using Women
Updated February 2009
|
|
NEW: Care of the Hospitalized HIV-Infected Substance User
Posted March 2009
|
|
Substance Use and Dependence Among HIV-Infected Adolescents and Young Adults
Posted February 2009
|
|
Appendix I: Criteria for Substance Dependence
Updated January 2008
|
|
Appendix II: Common Screening Tools for Identifying Substance and Alcohol Problems
Updated November 2007
|
|
Appendix III: The Fagerstrom Test for Nicotine Dependence
Updated February 2008
|
|
Appendix IV: Organizations Providing Co-Located HIV Care Within Drug Treatment Facilities
Updated February 2009
|
|
Appendix V: AIDS Institute-Funded Harm-Reduction Programs
Posted February 2009
|
|
Appendix VI: Guidance on the Use of Buprenorphine in HIV-Infected Patients
Posted February 2009
|
|
Appendix VII: Antiretroviral Therapy: Hepatic Impairment Dosing
Updated December 2009
|
|
Appendix VIII: Drugs Used for Smoking Cessation
Updated July 2009
|
|
Appendix IX: New York State Adherence Services Contact List
Updated February 2009
|
|
Appendix X: Advantages and Disadvantages of Adherence Measures
Updated June 2005
|
|
Appendix XI: Opioid Medication Interactions
Updated February 2009
|
|
Appendix XII: Drug Interactions Between ARV Agents and Recreational Drugs
Updated February 2009
|
|
Appendix XIII: Interactions Between HIV-Related Medications and Psychotropic Medications
Updated February 2009
|
|
Appendix XIV: Identification and Management of Withdrawal Symptoms
Posted February 2009
|
|
Contributors to the Guidelines
Updated March 2009
|
|